Study of Gefitinib and Pemetrexed as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation
Crossref DOI link: https://doi.org/10.1007/s12253-016-0067-4
Published Online: 2016-04-28
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
An, Chaolun
Zhang, Jiajun
Chu, Hongjun
Gu, Chunyan
Xiao, Feng
Zhu, Fengwei
Lu, Rujian
Shi, Hai
Zhang, Hongfei
Yi, Xin
Funding for this research was provided by:
Youth Research Fund of Nantong City Health Bureau (WQ2014034)
Text and Data Mining valid from 2016-04-28